Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings.
about
Developments in Intralesional Therapy for Metastatic MelanomaCurrent gene therapy for stomach carcinoma.Gene therapy of mesothelioma.Intralesional therapy for metastatic melanoma.Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levels.Dendritic cells infected with a vaccinia virus interleukin-2 vector secrete high levels of IL-2 and can become efficient antigen presenting cells that secrete high levels of the immunostimulatory cytokine IL-12.
P2860
Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Phase I clinical trial with IL ...... al and immunological findings.
@ast
Phase I clinical trial with IL ...... al and immunological findings.
@en
type
label
Phase I clinical trial with IL ...... al and immunological findings.
@ast
Phase I clinical trial with IL ...... al and immunological findings.
@en
prefLabel
Phase I clinical trial with IL ...... al and immunological findings.
@ast
Phase I clinical trial with IL ...... al and immunological findings.
@en
P2093
P2860
P356
P1476
Phase I clinical trial with IL ...... al and immunological findings.
@en
P2093
Courtney M
Fridman WH
Herrmann R
Jantscheff P
Pouillart P
P2860
P2888
P304
P356
10.1054/BJOC.2000.1492
P407
P577
2000-12-01T00:00:00Z
P5875
P6179
1006413185